Natasha Z Anita, Nathan Herrmann, Si Won Ryoo, Chelsi Major-Orfao, William Z Lin, Felicia Kwan, Shiropa Noor, Jennifer S Rabin, Susan Marzolini, Sean Nestor, Myuri T Ruthirakuhan, Bradley J MacIntosh, Maged Goubran, Pearl Yang, Hugo Cogo-Moreira, Mark Rapoport, Damien Gallagher, Sandra E Black, Benjamin I Goldstein, Krista L Lanctôt, Paul I Oh, Ameer Y Taha, Walter Swardfager
AIMS: This study examined serum cytochrome P450-soluble epoxide hydrolase (CYP450-sEH) oxylipins and depressive symptoms together in relation to cognitive performance in individuals with type 2 diabetes mellitus (T2DM). METHODS: Clinically cognitively normal T2DM individuals were recruited (NCT04455867). Depressive symptom severity was assessed using the Beck Depression Inventory-II (BDI-II; total scores ≤13 indicated minimal depressive symptoms and ≥ 14 indicated significant depressive symptoms)...
July 22, 2024: Journal of Diabetes and its Complications